Research
Fubon Securities Upgrades Bora Pharmaceuticals to Buy from Neutral; Price Target is NT$520
Bora Pharmaceuticals (TPE:6472) has an average rating of overweight and mean price target of NT$477.71, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
TPE:6472
